Sequence type (ST) 239 with SCCmec type III methicillin-resistant Staphylococcus aureus (ST239-MRSA-III) is the most predominant multidrug-resistant clone in China. The subclone ST239-MRSA-III-t037 has been gradually replaced with ST239-MRSA-III-t030 since 2000. Subclones are characterized by drug resistance profiles. However, the mechanisms of the clonal dynamics and determinants of distinct drug resistance remain poorly understood. In the present study, 12 ST239-MRSA-III-t030 and 12 ST239-MRSA-III-t037 strains were collected from Chongqing, Guangzhou, and Shanghai; these strains were selected and investigated in terms of t030/t037 strain pairs. Independent growth curve assay revealed that the ST239-MRSA-III-t030 strains grew more rapidly, with significantly shorter doubling times, than the ST239-MRSA-III-t037 strains (p < 0.001). The ST239-MRSA-III-t037 strains exhibited slightly to moderately higher (3–13%) fitness cost than the ST239-MRSA-III-t030 strains in a competition assay in vitro. The ST239-MRSA-III-t037 strains yielded lower bacterial loads in the kidneys of the infected mice than the ST239-MRSA-III-t030 rivals in a coinfection assay (p < 0.05). The ST239-MRSA-III-t030 strains were resistant to rifampicin but susceptible to trimethoprim/sulfamethoxazole (SXT). In contrast, the ST239-MRSA-III-t037 strains were susceptible to rifampicin but resistant to SXT. The genetic determinants of the resistance to rifampicin and SXT in the MRSA strains were determined. Our results suggest that the relatively low fitness cost and characteristic drug resistance phenotype can help explain the current predominance of these ST239-MRSA-III-t030 strains in Chinese hospitals.
Get full access to this article
View all access options for this article.
References
1.
Aires-de-SousaM., CorreiaV., and de LencastreH.2008. Changing patterns in frequency of recovery of five methicillin-resistant Staphylococcus aureus clones in Portuguese hospitals: surveillance over a 16-year period. J. Clin. Microbiol., 46:2912–2917.
2.
BurtsM.L., WilliamsW.A., DeBordK., and MissiakasD.M.2005. EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections. Proc. Natl. Acad. Sci. U. S. A., 102:1169–1174.
3.
ChambersH.F., and DeleoF.R.2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol., 7:629–641.
4.
ChenH., LiuY., JiangX., ChenM., and WangH.2010. Rapid change of methicillin-resistant Staphylococcus aureus clones in a Chinese tertiary care hospital over a 15-year period. Antimicrob. Agents Chemother., 54:1842–1847.
5.
ChenY., LiuZ., DuoL., XiongJ., GongY., YangJ., et al.2014. Characterization of Staphylococcus aureus from distinct geographic locations in China: an increasing prevalence of spa-t030 and SCCmec type III. PLoS One, 9:e96255.
6.
ChengH., YuanW., ZengF., HuQ., ShangW., TangD., et al.2013. Molecular and phenotypic evidence for the spread of three major methicillin-resistant Staphylococcus aureus clones associated with two characteristic antimicrobial resistance profiles in China. J. Antimicrob. Chemother., 68:2453–2457.
7.
ConceiçãoT., Aires-de-SousaM., FüziM., TóthA., PásztiJ., UngváriE., et al.2007. Replacement of methicillin-resistant Staphylococcus aureus clones in Hungary over time: a 10-year surveillance study. Clin. Microbiol. Infect., 13:971–979.
8.
EnrightM.C., RobinsonD.A., RandleG., FeilE.J., GrundmannH., and SprattB.G.2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. U. S. A., 99:7687–7692.
9.
FariaN.A., OliveiraD.C., WesthH., MonnetD.L., LarsenA.R., SkovR., et al.2005. Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection. J. Clin. Microbiol., 43:1836–1842.
10.
FeilE.J., NickersonE.K., ChantratitaN., WuthiekanunV., SrisomangP., CousinsR., et al.2008. Rapid detection of the pandemic methicillin-resistant Staphylococcus aureus clone ST239, a dominant strain in Asian hospitals. J. Clin. Microbiol., 46:1520–1522.
11.
GaoW., CameronD.R., DaviesJ.K., KostouliasX., StepnellJ., TuckK.L., et al.2013. The RpoB H481Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus. J. Infect. Dis., 207:929–939.
12.
HarrisS.R., FeilE.J., HoldenM.T., QuailM.A., NickersonE.K., ChantratitaN., et al.2010. Evolution of MRSA during hospital transmission and intercontinental spread. Science, 327:469–474.
13.
HeW., ChenH., ZhaoC., ZhangF., LiH., WangQ., et al.2013. Population structure and characterisation of Staphylococcus aureus from bacteraemia at multiple hospitals in China: association between antimicrobial resistance, toxin genes and genotypes. Int. J. Antimicrob. Agents, 42:211–219.
14.
HorváthA., DobayO., KardosS., GhidánÁ., TóthÁ., PásztiJ., et al.2002. Varying fitness cost associated with resistance to fluoroquinolones governs clonal dynamic of methicillin-resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis., 31:2029–2036.
15.
HuovinenP., SundstromL., SwedbergG., and SkoldO.1995. Trimethoprim and sulfonamide resistance. Antimicrob. Agents Chemother., 39:279–289.
16.
KadlecK., and SchwarzS.2009. Identification of a novel trimethoprim resistance gene, dfrK, in a methicillin-resistant Staphylococcus aureus ST398 strain and its physical linkage to the tetracycline resistance gene tet(L). Antimicrob. Agents Chemother., 53:776–778.
17.
KnightG.M., BuddE.L., WhitneyL., ThornleyA., Al-GhuseinH., PlancheT., et al.2012. Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time. J. Antimicrob. Chemother., 67:2514–2522.
18.
LaurentF., LelievreH., CornuM., AndeneschF., CarretG., EtienneJ., et al.2001. Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. J. Antimicrob. Chemother., 47:277–283.
19.
LiH., ZhaoC., ChenH., ZhangF., HeW., WangX., et al.2013. Identification of gene clusters associated with host adaptation and antibiotic resistance in Chinese Staphylococcus aureus isolates by microarray-based comparative genomics. PLoS One, 8:e53341.
20.
LiuY., WangH., DuN., ShenE., ChenH., NiuJ., et al.2009. Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals. Antimicrob. Agents Chemother., 53:512–518.
21.
MatsuoM., HishinumaT., KatayamaY., CuiL., KapiM., and HiramatsuK.2011. Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3. Antimicrob. Agents Chemother, 55:4188–95.
22.
NielsenK.L., PedersenT.M., UdekwuK.I., PetersenA., SkovR.L., HansenL.H., et al.2012. Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic. J. Antimicrob. Chemother., 67:1325–1332.
23.
NurjadiD., OlalekanA.O., LayerF., ShittuA.O., AlabiA., GhebremedhinB., et al.2014. Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe. J. Antimicrob. Chemother., 69:2361–2368.
24.
O'NeillA.J., HuovinenT., FishwickC.W., and ChopraI.2006. Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob. Agents Chemother., 50:298–309.
25.
SekiguchiJ., TharavichitkulP., Miyoshi-AkiyamaT., ChupiaV., FujinoT., AraakeM., et al.2005. Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454). Antimicrob. Agents Chemother., 49:3948–3951.
26.
SmythD.S., McDougalL.K., GranF.W., ManoharanA., EnrightM.C., SongJ.H., et al.2010. Population structure of a hybrid clonal group of methicillin-resistant Staphylococcus aureus, ST239-MRSA-III. PLoS One, 5:e8582.
27.
SolaC., CortesP., SakaH.A., VindelA., and BoccoJ.L.2006. Evolution and molecular characterization of methicillin-resistant Staphylococcus aureus epidemic and sporadic clones in Cordoba, Argentina. J. Clin. Microbiol., 44:192–200.
28.
VickersA.A., PotterN.J., FishwickC.W., ChopraI., and O'NeillA.J.2009. Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques. J. Antimicrob. Chemother., 63:1112–1117.
29.
WangZ., ZhouH., WangH., ChenH., LeungK.K., et al.2014. Comparative genomics of methicillin-resistant Staphylococcus aureus ST239: distinct geographical variants in Beijing and Hong Kong. BMC Genomics, 15:529.
30.
YamamotoT., TakanoT., HiguchiW., IwaoY., SingurO., RevaI., et al.2012. Comparative genomics and drug resistance of a geographic variant of ST239 methicillin-resistant Staphylococcus aureus emerged in Russia. PLoS One, 7:e29187.
31.
YuanW., HuQ., ChengH., ShangW., LiuN., HuaZ., et al.2013. Cell wall thickening is associated with adaptive resistance to amikacin in methicillin-resistant Staphylococcus aureus clinical isolates. J. Antimicrob. Chemother., 68:1089–1096.
32.
ZhouW., ShanW., MaX., ChangW., ZhouX., LuH., et al.2012. Molecular characterization of rifampicin-resistant Staphylococcus aureus isolates in a Chinese teaching hospital from Anhui, China. BMC Microbiol., 12:240.
